Back to search

United Kingdom· GB-APID-27373011000001104

D-Forte 50,000unit capsules

A ergocalciferol product containing ergocalciferol, registered in United Kingdom by Go-Kyo Science Ltd. The same ATC class is registered in 7 of our 19 countries.

ATC A11CC01

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedD-Forte 50,000unit capsulesATCA11CC01REGISTER NO.GB-APID-2737301100000…PACKS LISTED1CHECKEDSeptember 13, 2026

Where it is registered

Ergocalciferol is registered in 7 of 19 countries.

Countries holding a registration under ATC A11CC01 (ergocalciferol), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 5 of them publish a price we can compare per daily dose

Ergocalciferol · ATC A11CC01

7 / 19 countries

  • Canada
  • Czechiaprice
  • Finlandprice
  • Franceprice
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Ergocalciferol
Manufacturer
Go-Kyo Science Ltd
Country
United Kingdom (GB)
ATC code
A11CC01
ATC class
Ergocalciferol
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5028624037061

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

68 interactions on record for ergocalciferol.

Graded by severity as the source publishes them — 10 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Ergocalciferol · interactions on record

68 records

  • 10 severe
  • 56 moderate
  • 2 minor

Most severe, free to view

  • DihydrotachysterolA11CC02severe
  • CalcitriolA11CC04severe
  • ColecalciferolA11CC05severe
  • CalcifediolA11CC06severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ergocalciferol in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ergocalciferol products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Czechia · Calciferol Bbp
  • France · Sterogyl, Sterogyl 15 "a"
  • Slovakia · Calciferol Bbp

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fb3fd071-f850-4ff4-84e8-ed75e959c05e
GET /v1/drugs/fb3fd071-f850-4ff4-84e8-ed75e959c05e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "27373011000001104",
  "desc": "D-Forte 50,000unit capsules (Go-Kyo Science Ltd)",
  "form": "Oral capsule",
  "vpid": "41984611000001108",
  "source": "dmd",
  "vtm_id": "775811005",
  "strength": "1.25 mg",
  "substance": "Ergocalciferol",
  "ingredient": "Ergocalciferol",
  "supplier_code": "25119211000001105"
}

See everything about ergocalciferol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.